141 related articles for article (PubMed ID: 22117833)
1. Bronchioloalveolar differentiation in lung adenocarcinomas.
Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.
Sarantopoulos GP; Gui D; Shintaku P; Hong L; Wang YY; Yap CS; Fishbein MC
Arch Pathol Lab Med; 2004 Apr; 128(4):406-14. PubMed ID: 15043468
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
5. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
Lau SK; Desrochers MJ; Luthringer DJ
Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
[TBL] [Abstract][Full Text] [Related]
6. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
Goldstein NS; Thomas M
Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
[TBL] [Abstract][Full Text] [Related]
8. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
10. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
11. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
[TBL] [Abstract][Full Text] [Related]
12. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. An immunohistochemical study.
Ohori NP; Yousem SA; Griffin J; Stanis K; Stetler-Stevenson WG; Colby TV; Sonmez-Alpan E
Am J Surg Pathol; 1992 Jul; 16(7):675-86. PubMed ID: 1326898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K
Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.
Ebbert JO; Chhatwani L; Aubry MC; Wampfler J; Stoddard S; Zhang F; Qiao G; de Andrade M; Yang P
J Thorac Oncol; 2010 Aug; 5(8):1213-20. PubMed ID: 20592627
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non-mucinous tumours.
Guedj N; Couvelard A; Arcangeli G; Dubois S; Thabut G; Lesèche G; Fournier M; Degott C; Groussard O
Histopathology; 2004 Mar; 44(3):251-6. PubMed ID: 14987229
[TBL] [Abstract][Full Text] [Related]
17. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
[TBL] [Abstract][Full Text] [Related]
18. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Wislez M; Antoine M; Baudrin L; Poulot V; Neuville A; Pradere M; Longchampt E; Isaac-Sibille S; Lebitasy MP; Cadranel J
Lung Cancer; 2010 May; 68(2):185-91. PubMed ID: 19581016
[TBL] [Abstract][Full Text] [Related]
19. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ
J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and immunocytochemical studies of bronchioloalveolar carcinoma at Duke University Medical Center, 1968-1986.
Elson CE; Moore SP; Johnston WW
Anal Quant Cytol Histol; 1989 Aug; 11(4):261-74. PubMed ID: 2548519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
